Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Public doubts about vaccination safety and resistance against vaccination.

Streefland PH.

Health Policy. 2001 Mar;55(3):159-72.

PMID:
11164965
2.

Patterns of vaccination acceptance.

Streefland P, Chowdhury AM, Ramos-Jimenez P.

Soc Sci Med. 1999 Dec;49(12):1705-16.

PMID:
10574240
3.

Public opponents of vaccination: a case study.

Leask J, McIntyre P.

Vaccine. 2003 Dec 1;21(32):4700-3.

PMID:
14585678
4.
5.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
6.
8.

Training needs for mid-level managers and immunisation coverage in Western Kenya.

Ayaya SO, Liechty E, Conway JH, Kamau T, Esamai FO.

East Afr Med J. 2007 Jul;84(7):342-52.

PMID:
17886429
9.

Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.

Rosenthal J, Rodewald L, McCauley M, Berman S, Irigoyen M, Sawyer M, Yusuf H, Davis R, Kalton G.

Pediatrics. 2004 Apr;113(4):e296-302.

PMID:
15060256
10.

Immunisation policy: from compliance to concordance?

Vernon JG.

Br J Gen Pract. 2003 May;53(490):399-404. Erratum in: Br J Gen Pract. 2003 Jun;53(491):494.

11.

Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.

Salmon DA, Moulton LH, Omer SB, Chace LM, Klassen A, Talebian P, Halsey NA.

Pediatrics. 2004 Jun;113(6):e552-9.

PMID:
15173536
12.

Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic review.

Falagas ME, Zarkadoulia E.

Curr Med Res Opin. 2008 Jun;24(6):1719-41. doi: 10.1185/03007990802085692. Epub 2008 May 9. Review.

PMID:
18474148
13.

Healthcare workers who elected not to receive smallpox vaccination.

Wortley PM, Schwartz B, Levy PS, Quick LM, Evans B, Burke B.

Am J Prev Med. 2006 Mar;30(3):258-65.

PMID:
16476643
14.

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.

Goldie SJ, O'Shea M, Diaz M, Kim SY.

Reprod Health Matters. 2008 Nov;16(32):86-96. doi: 10.1016/S0968-8080(08)32409-4.

PMID:
19027626
15.

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.

Schaetti C, Hutubessy R, Ali SM, Pach A, Weiss MG, Chaignat CL, Khatib AM.

BMC Public Health. 2009 Apr 7;9:99. doi: 10.1186/1471-2458-9-99.

16.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

17.

An attempt to swindle nature: press anti-immunisation reportage 1993-1997.

Leask JA, Chapman S.

Aust N Z J Public Health. 1998 Feb;22(1):17-26. Review.

PMID:
9599848
18.

A risk-benefit analysis of vaccination.

Heininger U.

Vaccine. 2009 Dec 30;27 Suppl 6:G9-G12. doi: 10.1016/j.vaccine.2009.10.010.

PMID:
20006145
19.
20.

Attitudes of healthcare workers in U.S. hospitals regarding smallpox vaccination.

Yih WK, Lieu TA, RĂªgo VH, O'Brien MA, Shay DK, Yokoe DS, Platt R.

BMC Public Health. 2003 Jun 11;3:20.

Items per page

Supplemental Content

Write to the Help Desk